List view / Grid view

Good Distribution Practice (GDP)



Innovation in pharma manufacturing quality systems

16 November 2022 | By

Over the last 10 years, there has been an important change of focus in pharma towards biotech products and personalised therapies. These important new treatments are now emerging into manufacturing, with implications for the way that quality is monitored, managed and assured. Dr Eduard Cayón sets out some practical advice.